Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

Brilacidin had an IV treatment effect in one day, equivalent to 7 days on a Daptomycin IV. I'm neither shilling nor bashing Brilacidin for ABSSSI. There is some obvious treatment efficacy potential and more side effect occurrences than Daptomycin. An FDA PH3 could set the record straight. If FDA felt the Brilacidin side effects were too severe when balanced against its anti-biotic potentials, it would not have worked with IPIX regarding protocols for a PH3. IPIX stated it did not have the estimated 34 million to conduct the PH3.